EP4 receptor signalling in immature B cells involves cAMP and NF-κB dependent pathways

Area of Science:

• Immunology
• Cell Biology
• Molecular Biology

Background:

• Immature B cells play a critical role in immune responses.
• Prostaglandin E2 (PGE2) is known to influence immune cell function.
• The specific signaling pathways of EP4 receptor in immature B cells require further elucidation.

Purpose of the Study:

• To delineate the signaling properties of the EP4 receptor in immature B cells.
• To understand the mechanisms by which PGE2 affects immature B cell proliferation.

Main Methods:

• WEHI 231 cells were utilized as a model for immature B lymphocytes.
• Proliferation was assessed using MTS assays.
• Cyclic adenosine monophosphate (cAMP) levels, protein phosphorylation (VASP, ERK1/2, IκB-α), NF-κB activation, and Egr-1 mRNA expression were analyzed using ELISA, Western blot, and qPCR.

Main Results:

• EP4 receptor activation by PGE2 suppresses WEHI 231 cell proliferation.
• This suppression is mediated by increased cAMP levels and activation of protein kinase A.
• EP4 signaling inhibits NF-κB activation through IκB-α phosphorylation inhibition and p65 cytoplasmic accumulation, without involving PI3K.
• Early growth response factor 1 (Egr-1) mRNA levels were also affected.

Conclusions:

• EP4 receptor signaling is a key mediator of PGE2's growth-suppressive effects on immature B cells.
• The pathway involves cAMP elevation and NF-κB inhibition.
• Targeting the EP4 receptor presents potential therapeutic strategies for autoimmune diseases, leukemia, and lymphomas.